Lataa...
The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram
BACKGROUND: Citalopram is the most commonly prescribed antidepressant in Canada. Concerns have been raised about its cardiac safety, and a dose-dependent prolongation of the QT interval has been documented. Drug interactions involving concomitant use of other medications that prolong the QT interval...
Tallennettuna:
| Julkaisussa: | Drug Healthc Patient Saf |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4547663/ https://ncbi.nlm.nih.gov/pubmed/26316822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S91046 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|